Pharma channel feed – Endpoints News

Pharma channel feed

Amid Trump’s research cuts, commission says US risks losing biotech race without $15B investment

3 months ago

HHS says it may revisit anti-obesity drug policies after dropping Biden-era proposal

3 months ago

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law

3 months ago

PureTech rejects cash exit proposal from Nordic Capital, investment firm says it won't make an offer

3 months ago

Rare disease hub at CDER and CBER faces new reality with staff crunch

3 months ago

Drug tool and packaging makers to feel brunt of Trump tariffs, analysts say

3 months ago

RFK Jr. won’t testify before key Senate committee this week on HHS overhaul

3 months ago

Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing

3 months ago

Rhythm touts Phase 3 win for rare obesity drug in people with brain damage

3 months ago

GSK’s newest neuro pact is with ABL Bio, a Sanofi-partnered South Korean biotech

3 months ago

Trump administration leaves obesity coverage expansion out of new Medicare rule

3 months ago

GSK and Pfizer resolve RSV vaccine patent fight

3 months ago

Novavax’s held-up approval package may signal warning for Covid vaccine makers

3 months ago

FTC chairman seeks to revive PBM case

3 months ago

China's retaliatory tariffs on US could mean more headwinds for drugmakers

3 months ago

States sue NIH over 'devastating' grant disruptions amid health agency shakeup

3 months ago

Senate confirms Dr. Oz to lead Medicare agency amid HHS overhaul

3 months ago

DOJ attorney says Boehringer Ingelheim has 'tremendous leverage' in IRA negotiations

3 months ago

FDA approves Amgen's Uplizna in IgG4-related disease

3 months ago

FDA will consolidate to five 'shared services offices,' according to memo to Hill staffers

3 months ago

Aldeyra gets another CRL for its dry eye disease drug that AbbVie has the option to co-develop

3 months ago

Chaotic tariff rollout leaves as many questions as answers for drugmakers

3 months ago

Trump’s broad tariffs exempt pharma — but for how long?

3 months ago

FDA cuts stir buyer’s remorse for some biopharma leaders, once excited by Trump

3 months ago

First page Previous page 11 12 131415 16 17 Next page Last page